Evergreen Solar and SunPower Participate in Equity Research Conducted by Stock.com

Comprehensive analytical research on the solar energy industry is being done by www.stock.com. The website has completed the analysis of the companies, SunPower and Evergreen Solar. It is anticipated that the solar energy market would grow explosively in the near future. If a private sector investment of $100 billion is ploughed into the solar energy market it would make the solar energy capacity to reach 4.2% of the total US electricity by the year 2020.

The expenses involved in purchasing solar equipment have decreased to almost half of the original costs, and hence this factor makes the solar plant installations a viable proposition for both homeowners and commercial organizations. If government support is also added to the equation then the industry’s rapid growth is assured. For the period of 2009-2010, the industry growth was by 80% for a total capacity of 12.9 GW.

Stock.com is an online platform, a place for investors to access freely the analyst’s research and outlook on companies such as SunPower and Evergreen Solar by registering for a free membership facility. The site also gives details about the past successes and future performances of the companies. The ultimate success of a company depends on many factors, such as low production costs or production of ultra efficient solar panels. However China is proving to be a fierce competitor as it has the dual benefits of governmental support and low production costs, which seems to attract many American producers.

At present China sells 40% of its solar equipment to California. But American solar companies are planning to capitalize on the increasing protectionist attitudes of the consumers and market their products with a Made in the USA label attached. Both SunPower and Evergreen Solar based in the US are ready to be unleashed in the market. The Evergreen Solar results would be seen in the website on the 1st of November, while SunPower results would be seen on 11th November.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.